PRISM MediaWire

Understanding Autism Spectrum Disorder in Children: Insights and Advances in Treatment

New York, March 08, 2024 - PRISM MediaWire - Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by challenges in social interaction, communication, and repetitive behaviors. It affects individuals differently and can range from mild to...

8 March 2024

Food and FoodTech

Brewing Excellence: A Deep Dive into Black Rifle Coffee's Rise in the Coffee Industry

New York, March 07, 2024 - PRISM MediaWire - In the ever-evolving landscape of the coffee industry, one brand has captured the attention of consumers and aficionados alike with its bold flavors, unapologetic branding, and unwavering commitment to veterans' causes. Black ...

7 March 2024

Medical Devices

Nexalin Tackles Sleepless Nights with Innovative Insomnia Device

New York, March 07, 2024 - PRISM MediaWire - In a world where stress and anxiety have become prevalent, sleep disorders like insomnia have emerged as significant health concerns affecting millions of individuals globally. Sleeplessness not only impacts one's physical wel...

7 March 2024

Medical Devices

Neuronetics Announces Substantial Growth in 2023, Enhances Accessibility to Neurohealth Therapy; Stock Prices Surge by 23%

New York, March 06, 2024 - PRISM MediaWire - Neuronetics, Inc. (NASDAQ: STIM), a prominent medical technology firm focused on neurohealth therapies, disclosed notable financial and operational milestones for the fourth quarter and full-year of 2023. The company has achie...

6 March 2024

Electric Vehicles

GreenPower Introduces Newest Innovation: GP Truck Body, Enhancing One-Stop EV Solution

New York, March 06, 2024 - PRISM MediaWire - GreenPower Motor Company Inc. (NASDAQ: GP) (TSXV: GPV), renowned for its lineup of all-electric, zero-emission medium and heavy-duty vehicles, has initiated the establishment of GP Truck Body, a novel business segment dedicate...

6 March 2024

Lipella Pharmaceuticals to Progress Development of Oral Graft-versus-Host-Disease Treatment Candidate

New York, March 06, 2024 - PRISM MediaWire - "Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) secures FDA Approval for Investigational New Drug (IND) Application, Advancing Clinical Testing of LP-410 for Oral Graft-Versus-Host Disease (GvHD) Treatment. Clinical Study Set to ...

6 March 2024

SKYX Enters Collaboration with Golden Lighting to Introduce Smart Plug & Play Products into Expanded Sales Channels

New York, March 06, 2024 - PRISM MediaWire - SKYX Platforms Corp. (Nasdaq: SKYX) announces a strategic partnership with Golden Lighting, a renowned manufacturer and premier provider of elegant lighting solutions. This collaboration aims to facilitate SKYX's introduction ...

6 March 2024

IceCure's ProSense® Achieves Complete Tumor Reduction in Early-Stage Breast Cancer

New York, March 06, 2024 - PRISM MediaWire - IceCure Medical Ltd. (Nasdaq: ICCM) has disclosed novel findings from an initial, autonomous breast cancer investigation, revealing a median tumor reduction of 100% at both six and twelve months subsequent to cryoablation in w...

6 March 2024

Sports Gear and Apparel

DRYWORLD Brands (IBGR) Strategically Positions Itself for Game-Changing Impact in 2024 Following Dynamic Moves in 2023

New York, March 05, 2024 - PRISM MediaWire - Today, DRYWORLD Brands, Inc. ($IBGR), a leading global sports brand renowned for premium performance, delivered its annual corporate update to the investment community. The update showcased remarkable achievements, including a...

5 March 2024

Topline Data Anticipated for Suicidal Bipolar Depression Treatment Trial by NRx

New York, March 05, 2024 - PRISM MediaWire - NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) achieves 'Last Patient, Last Visit' milestone in Phase 2b/3 Trial of NRX-101 for suicidal treatment-resistant bipolar depression. The company confirms completion of the 74th and final e...

5 March 2024